Results 241 to 250 of about 1,023,256 (260)

Correction to: Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB-Containing Vaccines. [PDF]

J Infect Dis
europepmc   +1 more source

Deciphering Factors Linked With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Susceptibility in the Swiss HIV Cohort Study. [PDF]

J Infect Dis
Abela IA, Hauser A, Schwarzmüller M, Pasin C, Kusejko K, Epp S, Cavassini M, Battegay M, Rauch A, Calmy A, Notter J, Bernasconi E, Fux CA, Leuzinger K, Perreau M, Ramette A, Gottschalk J, Schindler E, Wepf A, Marconato M, Manz MG, Frey BM, Braun DL, Huber M, Günthard HF, Trkola A, Kouyos RD, Swiss HIV Cohort Study .   +27 more
europepmc   +1 more source

Detection of Severe Acute Respiratory Syndrome Coronavirus 2 in Pregnant Women Treated with Nirmatrelvir/Ritonavir (Paxlovid) Using Salivary Polymerase Chain Reaction: A Prospective Cohort Study. [PDF]

Microorganisms
Tseng CH, Lin CW, Tsai PY, Su MT.
europepmc   +1 more source

Correction to: Development of an Effective Immune Response in Adults With Down Syndrome After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination. [PDF]

Clin Infect Dis
europepmc   +1 more source

Severe acute respiratory syndrome coronavirus 2-reactive salivary antibody detection in South Carolina emergency healthcare workers, September 2019-March 2020. [PDF]

Epidemiol Infect
Meltzer HC, Goodwin JL, Fowler LA, Britt TW, Pirrallo RG, Grier JT.   +5 more
europepmc   +1 more source

Effect of metabolic dysfunction-associated steatotic liver disease on BNT162b2 immunogenicity against the severe acute respiratory syndrome coronavirus 2 omicron variant. [PDF]

J Gastroenterol Hepatol
Lam LK, Tan JT, Ooi PH, Zhang R, Chan KH, Mao X, Hung IFN, Seto WK, Yuen MF, Cheung KS.   +9 more
europepmc   +1 more source

Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in Seoul, Korea. [PDF]

Infect Chemother
Sim J, Son E, Kwon M, Hwang EJ, Lee YH, Choe YJ.   +5 more
europepmc   +1 more source

Patient and Immunological Factors Associated With Delayed Clearance of Mucosal Severe Acute Respiratory Syndrome Coronavirus 2 RNA and Symptom Persistence. [PDF]

J Infect Dis
Stone M, Spencer BR, Warden DE, Fink RV, Saa P, Leddy J, Mulach-Vannoy J, Townsend R, Krysztof D, Hughes AN, Di Germanio C, Kessler DA, Kleinman S, Busch MP, Norris PJ.   +14 more
europepmc   +1 more source

Longitudinal Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 T-Cell Immunity Over 2 Years Following Vaccination and Infection. [PDF]

J Infect Dis
Juhl AK, Dietz LL, Søgaard OS, Reekie J, Nielsen H, Johansen IS, Benfield T, Wiese L, Stærke NB, Jensen TØ, Olesen R, Iversen K, Fogh K, Bodilsen J, Madsen LW, Lindvig SO, Raben D, Andersen SD, Hvidt AK, Andreasen SR, Baerends EAM, Lundgren J, Østergaard L, Tolstrup M, ENFORCE Study Group .   +24 more
europepmc   +1 more source

Early, Robust Mucosal Secretory Immunoglobulin A but not Immunoglobulin G Response to Severe Acute Respiratory Syndrome Coronavirus 2 Spike in Oral Fluid Is Associated With Faster Viral Clearance and Coronavirus Disease 2019 Symptom Resolution. [PDF]

J Infect Dis
Pisanic N, Antar AAR, Hetrich MK, Demko ZO, Zhang X, Spicer K, Kruczynski KL, Detrick B, Clarke W, Knoll MD, Thomas DL, Dawood FS, Veguilla V, Karron RA, Manabe YC, Heaney CD.   +15 more
europepmc   +1 more source